CLUSTERIN ANTISENSE INHIBITOR OGX-011 SYNERGIZES ACTIVITY OF SECOND GENERATION ANTI-ANDROGEN, MDV3100, IN CASTRATE RESISTANT PROSTATE CANCER MODEL

被引：0
|
作者：
Matsumoto, Hiroaki
Kuruma, Hidetoshi
Zoubeidi, Amina
Fazli, Ladan
Gleave, Martin
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.192
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
125
引用
收藏
页码：E52 / E53
页数：2
相关论文
共 19 条
  • [1] An evaluation of clusterin antisense inhibitor OGX-011 in combination with the second-generation antiandrogen MDV3100 in a castrate-resistant prostate cancer model.
    Matsumoto, H.
    Kuruma, H.
    Zoubeidi, A.
    Fazli, L.
    Gleave, M. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Clusterin knockdown synergizes activity of second generation anti-androgen, MDV3100, through enhancing AR degradation and repression of FKBP52 in castrate resistant prostate cancer model
    Matsumoto, H.
    Kuruma, H.
    Zoubeidi, A.
    Zardan, A.
    Fazli, L.
    Ettinger, S.
    Matsuyama, H.
    Gleave, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E235 - E235
  • [3] Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer
    Zielinski, Robert
    Chi, Kim N.
    [J]. FUTURE ONCOLOGY, 2012, 8 (10) : 1239 - 1251
  • [4] Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer
    Chi, Kim N.
    Zoubeidi, Amina
    Gleave, Martin E.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (12) : 1955 - 1962
  • [5] CUSTIRSEN (OGX-011): A SECOND-GENE RATION ANTISENSE INHIBITOR OF CLUSTERIN FOR THE TREATMENT OF CANCER
    Gleave, Martin
    [J]. JOURNAL OF ANDROLOGY, 2009, 30 : 14 - 14
  • [6] CO-TARGETING CLUSTERIN AND THE ANDROGEN RECEPTOR WITH OGX-011 AND AN AR ANTISENSE SYNERGISTICALLY ENHANCES ACTIVITY OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER
    Yamamoto, Yoshiaki
    Matsumoto, Hiroaki
    Kuruma, Hidetoshi
    Beraldi, Eliana
    Zhou, Tianyuan
    Kim, Youngsoo
    Monia, Brett P.
    MacLeod, A. Robert
    Fazli, Ladan
    Zoubeidi, Amina
    Gleave, Martin
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E260 - E261
  • [7] Modulation of intracrine androgen signaling in bone metastatic castrate resistant prostate cancer (bmCRPC) by MDV3100
    Efstathiou, Eleni
    Titus, Mark
    Tsayachidou, Dimitra
    Wen, Sijin
    Hoang, Anh
    Ashe, Robynne
    Karlou, Maria
    Berman, Craig
    Troncoso, Patricia
    Mohler, James
    Logothetis, Christopher J.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Clusterin Inhibition Using OGX-011 Synergistically Enhances Hsp90 Inhibitor Activity by Suppressing the Heat Shock Response in Castrate-Resistant Prostate Cancer
    Lamoureux, Francois
    Thomas, Christian
    Yin, Min-Jean
    Kuruma, Hidetoshi
    Beraldi, Eliana
    Fazli, Ladan
    Zoubeidi, Amina
    Gleave, Martin E.
    [J]. CANCER RESEARCH, 2011, 71 (17) : 5838 - 5849
  • [9] ANTISENSE INHIBITOR TARGETING FULL LENGTH ANDROGEN RECEPTOR AND ITS SPLICE VARIANTS SUPPRESSES MDV3100 RESISTANT PROSTATE CANCER CELL GROWTH
    Yamamoto, Yoshiaki
    Beraldi, Eliana
    Kuruma, Hidetoshi
    Matsumoto, Hiroaki
    Loriot, Yohann
    Wyatt, Alexander
    Mo, Fan
    Zhou, Tianyuan
    Kim, Youngsoo
    Monia, Brett
    MacLeod, A. Robert
    Fazli, Ladan
    Zoubeidi, Amina
    Gleave, Martin
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E130 - E130
  • [10] Effect of generation 2.5 antisense inhibitor of androgen receptor on MDV3100-resistant prostate cancer cell growth in vitro and in vivo
    Yamamoto, Yoshiaki
    Beraldi, Eliana
    Loriot, Yohann
    Zhou, Tianyuan
    Kim, Youngsoo
    Monia, Brett P.
    MacLeod, A. Robert
    Fazli, Ladan
    Zoubeidi, Amina
    Gleave, Martin Edwin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12